Paul Janssen

Source: Wikipedia, the free encyclopedia.

Paul Adriaan Jan Janssen
Janssen Pharmaceutica
SpouseDora Arts
Parent(s)Constant Janssen
Margriet Fleerackers

Paul Adriaan Jan, Baron Janssen (12 September 1926 – 11 November 2003) was a Belgian physician. He was the founder of

Janssen Pharmaceutica, a pharmaceutical company with over 20,000 employees[1] which is now a subsidiary of Johnson & Johnson
.

Early life and education

Paul Janssen was the son of Constant Janssen and Margriet Fleerackers.

He attended secondary school at the

magna cum laude from Ghent University.[2] He graduated with a postdoctoral degree in pharmacology at the same university in 1956, and studied at the Institute of Pharmacology of the University of Cologne.[3]

On 16 April 1957, he married Dora Arts.

Career

During his military service and until 1952, he worked at the Institute of Pharmacology of the

University of Ghent Institute of Pharmacology and Therapeutics, headed by Corneille Heymans, who had won the Nobel Prize for medicine in 1938.[citation needed
]

With a loan of fifty thousand

In 1956, Janssen received his

]

On 11 February 1958 he developed

Lomotil), was used in the Apollo program.[8][9]

In 1959, Janssen synthesized the potent opioid fentanyl based on SAR studies of meperidine.[citation needed] In the 1970s, he would improve upon the potency of fentanyl with the synthesis of Carfentanil.

In 1985, Janssen Pharmaceutical became the first Western pharmaceutical company to establish a factory in the People's Republic of China (

AIDS treatments.[12][13]

Altogether Janssen and his cadre of scientists discovered more than eighty new medications, four of which are on the

]

In 1991, he was elevated to the Belgian nobility by King Baudouin receiving the title of Baron.[citation needed]

Death

Janssen died in Rome in 2003, while attending the celebration of the 400th anniversary of the founding of the Pontifical Academy of Sciences, of which he had been a member since 1990.[14]

Popularity polls

  • In 2005 he finished as runner up, after Father Damien, in the poll for The Greatest Belgian organized by the regional Flemish television.[15]
  • On Wednesday 22 October 2008, Paul Janssen was awarded the title of Most Important Belgian Scientist, an initiative of the Eos magazine.[16]

See also

References

  1. ^ Paul Lewi, Obituary of Dr Paul Janssen (1926–2003), Drug Discovery Today, Volume 9, Issue 10, 15 May 2004, Pages 432–433
  2. ^ Dr. Paul Janssen, 77, Dies; Founder of a Drug Company - website of the newspaper The New York Times
  3. LA Times
  4. ^ I. Oransky, Paul Janssen, The Lancet, Volume 363, Issue 9404, Pages 251–251
  5. ^ B. Granger, S. Albu, The Haloperidol Story, Annals of Clinical Psychiatry (after 1 January 2004), Volume 17, Number 3, Number 3/July–September 2005, pp. 137–140(4)
  6. S2CID 20490363
    . Retrieved 7 May 2011.
  7. .
  8. ^ "W. Royce Hawkins, M.D., John F. Zieglschmid, M.D., Clinical aspects of crew health". Lsda.jsc.nasa.gov. Archived from the original on 23 February 2012. Retrieved 12 March 2012.
  9. ^ "Apollo Medical Kits". History.nasa.gov. Retrieved 12 March 2012.
  10. ^ Magiels G, Paul Janssen. Pionier in farma en in China, Houtekiet, 2005
  11. ^ molmo.be Archived 31 July 2009 at the Wayback Machine
  12. ^ Yven Van Herrewege, Guido Vanham, Jo Michiels, Katrien Fransen, Luc Kestens, Koen Andries, Paul Janssen, and Paul Lewi, A Series of Diaryltriazines and Diarylpyrimidines Are Highly Potent Nonnucleoside Reverse Transcriptase Inhibitors with Possible Applications as Microbicides, Antimicrob Agents Chemother. 2004 October; 48(10): 3684–3689
  13. ^ "New AIDS Drug Discoveries To Battle Drug-Resistant HIV Strains". Sciencedaily.com. 20 August 2002. Retrieved 12 March 2012.
  14. ^ Neuropsychopharmacology. "Thomas A Ban, Paul Adriaan Jan Janssen, 1926–2003, Neuropsychopharmacology (2004) 29, 1579–1580". Nature.com. Retrieved 12 March 2012.
  15. ^ "De Grootste Belg". De Standaard (in Dutch). Retrieved 4 October 2011.
  16. ^ "Most Important Belgian Scientist". Picture.belga.be. 22 October 2008. Archived from the original on 20 February 2012. Retrieved 12 March 2012.

Further reading

External links